Answers are grounded in this paper and cite their sources.
Vestibular schwannomas (VS) are increasingly being managed with LINAC-based stereotactic radiosurgery (SRS) or fractionated stereotactic radiotherapy (fSRT). There is a paucity of long-term outcomes especially in relation to post-treatment volumetric tumour and pseudoprogression data. 197 patients treated with LINAC-SRS (n = 92) and LINAC-fSRT (n = 105) between November 2003 and September 2019 were analysed. Tumour control was assessed volumetrically using MRI. The primary outcome was radiological VS control at last follow-up. The secondary outcomes were freedom from further intervention, serviceable hearing at last follow-up and incidence of new or worsened facial nerve palsy. Patients undergoing fSRT had larger pre-treatment tumour size (2.1 cm3 vs 1.0, p = 0.008). At a median follow-up of 10.9 years, radiological control rates were 94% for SRS and 91% for fSRT (p = 0.41). Rates of freedom from further surgical or radiation intervention were 98% and 97%, respectively. SRS showed a larger median pseudoprogression (≈75%). Facial nerve palsy and sensation changes were low and comparable between the groups. Hydrocephalus occurred more frequently after fSRT (9.8% vs. 1.1%, p = 0.021). LINAC-fSRT and LINAC-SRS are both associated with excellent long-term tumour control rates. Hydrocephalus was more common in patients after fSRT with the caveat these patients had a larger pre-treatment tumour volume.
No takes yet. Share an insight, caveat, or question.
Bakhsh et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: